Skip to main content
Fig. 3 | Journal of Experimental & Clinical Cancer Research

Fig. 3

From: EZH2 is increased in paediatric T-cell acute lymphoblastic leukemia and is a suitable molecular target in combination treatment approaches

Fig. 3

DZNep and Daunoblastine in Jurkat cell growth. Dose-dependent inhibitory effect of Daunoblastine (a) and DZNep (b) on Jurkat cells treated with different concentrations of DZNep or Daunoblastine at 48 and 72 h as described in Materials and Methods section. Percentage of cell growth induced by different concentrations of agents was evaluated with MTT assay. Each point is the mean of three different evaluations performed in at least three different experiments

Back to article page

Journal of Experimental & Clinical Cancer Research

ISSN: 1756-9966

Contact us